Olorinab
Olorinab Uses, Dosage, Side Effects, Food Interaction and all others data.
Olorinab is under investigation in clinical trial NCT03155945 (Tolerability, Pharmacokinetics, and Efficacy of APD371 in Subjects With Crohn's Disease Experiencing Abdominal Pain).
| Trade Name | Olorinab |
| Generic | Olorinab |
| Olorinab Other Names | Olorinab |
| Type | |
| Formula | C18H23N5O3 |
| Weight | Average: 357.414 Monoisotopic: 357.180089621 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Olorinab
